Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
11,82 CNY | +2,07 % | +2,87 % | +7,85 % |
19/04 | Hunan Fangsheng Pharmaceutical Co. Resultados del primer trimestre finalizado el 31 de marzo de 2024 | CI |
10/04 | Las fábricas de Fangsheng Pharma pasan la inspección GMP | MT |
Resumen de negocios
Número de empleados: 1 686
Ventas por actividad
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cardiovascular and Cerebrovascular Disease Medication
23,6
%
| 449 | 25,1 % | 385 | 23,6 % | -14,34 % |
Musculoskeletal Systemic Drugs
22,0
%
| 368 | 20,5 % | 359 | 22,0 % | -2,34 % |
Other
17,4
%
| 438 | 24,4 % | 284 | 17,4 % | -35,14 % |
Medication for Children
11,6
%
| 151 | 8,4 % | 188 | 11,6 % | +24,74 % |
Respiratory System Medication
11,0
%
| 140 | 7,8 % | 180 | 11,0 % | +27,96 % |
Gynecological Diseases Medication
5,7
%
| 109 | 6,1 % | 92 | 5,7 % | -15,21 % |
Anti-infective Drugs
5,0
%
| 96 | 5,4 % | 82 | 5,0 % | -14,98 % |
Other Business
3,6
%
| 41 | 2,3 % | 59 | 3,6 % | +43,19 % |
Ventas por región
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 792 | 100,0 % | 1 629 | 100,0 % | -9,12 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Xiao Li Zhou
CEO | Chief Executive Officer | 51 | - |
Zai Chang Liu
DFI | Director of Finance/CFO | 50 | 17/06/21 |
43 | - | ||
Meng Gong
COO | Chief Operating Officer | 43 | - |
Bo Chen
BRD | Director/Board Member | 45 | 31/07/14 |
Bo Ru Zeng
IRC | Investor Relations Contact | 30 | - |
Shi He
SEC | Corporate Secretary | 39 | 22/01/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 19/09/23 |
Shou Ying Du
BRD | Director/Board Member | 64 | 01/05/20 |
Xiong Yuan
BRD | Director/Board Member | 59 | 16/11/21 |
Bo Chen
BRD | Director/Board Member | 45 | 31/07/14 |
Xiao Li Zhou
CEO | Chief Executive Officer | 51 | - |
Man Xiao
CHM | Chairman | 43 | - |
Meng Gong
COO | Chief Operating Officer | 43 | - |
Bo Ru Zeng
IRC | Investor Relations Contact | 30 | - |
Yue Xiao
BRD | Director/Board Member | 45 | 16/09/22 |
Xiang Mu Shen
BRD | Director/Board Member | 37 | 30/11/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 439 616 620 | 262 446 545 ( 59,70 %) | 1 145 000 ( 0,2605 %) | 59,70 % |
Información de la empresa
Hunan Fangsheng Pharmaceutical Co., Ltd.
299 Jiayun Road National High-Tech Indl Dev Zone
410205, Changsha
+
http://www.fangsheng.com.cnSector
Ventas por actividad
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,85 % | 718 M | |
+19,98 % | 43,48 mil M | |
+20,67 % | 22,65 mil M | |
+14,56 % | 14,73 mil M | |
+44,72 % | 12,04 mil M | |
-8,37 % | 7082,51 M | |
-0,05 % | 6787,61 M | |
-8,87 % | 5725,52 M | |
+11,90 % | 5473,11 M | |
-2,27 % | 4813,62 M |
- Bolsa de valores
- Acciones
- Acción 603998
- Empresa Hunan Fangsheng Pharmaceutical Co., Ltd.